S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Sigilon Therapeutics (SGTX) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

Sigilon Therapeutics Short Interest Data

Current Short Volume
8,200 shares
Previous Short Volume
10,100 shares
Change Vs. Previous Month
-18.81%
Dollar Volume Sold Short
$171,544.00
Short Interest Ratio / Days to Cover
0.1
Last Record Date
July 31, 2023
Outstanding Shares
2,510,000 shares
Float Size
1,420,000 shares
Short Percent of Float
0.58%
Today's Trading Volume
83,600 shares
Average Trading Volume
62,902 shares
Today's Volume Vs. Average
133%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Sigilon Therapeutics ?

Sign up to receive the latest short interest report for Sigilon Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SGTX Short Interest Over Time

SGTX Days to Cover Over Time

SGTX Percentage of Float Shorted Over Time


Sigilon Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20238,200 shares $171,544.00 -18.8%0.6%0.1 $20.92
7/15/202310,100 shares $214,625.00 -1.0%0.7%0.1 $21.25
6/30/202310,200 shares $229,602.00 +7.4%0.7%0.1 $22.51
6/15/20239,500 shares $48,070.00 +6.7%0.7%1.2 $5.06
5/31/20238,900 shares $37,380.00 -15.2%0.6%0.6 $4.20
5/15/202310,500 shares $69,464.85 -93.3%N/A0.6 $6.62
4/30/2023156,600 shares $114,318.00 +21.8%1.1%0.8 $0.73
4/15/2023128,600 shares $83,590.00 -5.8%0.9%0.6 $0.65
3/31/2023136,500 shares $126,958.65 -26.1%1.0%0.3 $0.93
3/15/2023184,600 shares $210,444.00 -24.9%1.3%0.5 $1.14
2/28/2023245,700 shares $267,813.00 +13.4%1.8%0.9 $1.09
2/15/2023216,700 shares $166,859.00 -5.6%1.0%0.9 $0.77
1/31/2023229,500 shares $166,066.20 +46.9%1.1%1 $0.72
1/15/2023156,200 shares $71,852.00 -5.1%0.7%0.7 $0.46
12/30/2022164,500 shares $57,575.00 -7.0%0.8%3.5 $0.35
12/15/2022176,800 shares $58,344.00 +11.8%0.9%3.7 $0.33
11/30/2022158,200 shares $62,394.08 +6.3%0.8%3.4 $0.39
11/15/2022148,800 shares $67,852.80 -5.9%0.8%3.6 $0.46
10/31/2022158,200 shares $79,416.40 +25.4%1.1%4.1 $0.50
10/15/2022126,200 shares $61,838.00 -9.7%0.9%3.1 $0.49
9/30/2022139,700 shares $70,548.50 -5.7%1.0%3.1 $0.51
9/15/2022148,200 shares $100,776.00 +6.5%1.0%2 $0.68
8/31/2022139,200 shares $86,526.72 +7.7%1.0%1.6 $0.62
8/15/2022129,300 shares $93,108.93 -9.6%0.9%1.3 $0.72
7/31/2022143,100 shares $101,601.00 +9.9%1.0%1.3 $0.71
7/15/2022130,200 shares $108,586.80 -17.3%0.9%1.1 $0.83
6/30/2022157,400 shares $130,642.00 -73.9%1.1%1.3 $0.83
6/15/2022603,300 shares $552,019.50 -9.2%4.3%5 $0.92
5/31/2022664,500 shares $503,691.00 +25.2%4.7%6.7 $0.76
5/15/2022530,600 shares $398,480.60 +11.6%3.7%5.9 $0.75
4/30/2022475,600 shares $499,380.00 +5.5%3.4%5.5 $1.05
4/15/2022450,800 shares $635,628.00 -4.1%3.2%5.1 $1.41
3/31/2022469,900 shares $690,753.00 +15.7%3.3%4.9 $1.47
3/15/2022406,200 shares $548,370.00 +13.3%2.9%3.9 $1.35
2/28/2022358,500 shares $519,825.00 +11.5%2.5%3 $1.45
2/15/2022321,500 shares $524,045.00 +31.8%2.3%2.3 $1.63
1/31/2022244,000 shares $475,800.00 +9.7%1.7%1.7 $1.95
1/15/2022222,400 shares $489,280.00 -4.7%1.6%1.5 $2.20
12/31/2021233,400 shares $644,184.00 -3.7%1.7%1.7 $2.76
12/15/2021242,400 shares $625,392.00 -15.5%1.7%1.8 $2.58













SGTX Short Interest - Frequently Asked Questions

What is Sigilon Therapeutics' current short interest?

Short interest is the volume of Sigilon Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 8,200 shares of SGTX short. 0.58% of Sigilon Therapeutics' shares are currently sold short. Learn More on Sigilon Therapeutics' current short interest.

What is a good short interest percentage for Sigilon Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.58% of Sigilon Therapeutics' floating shares are currently sold short.

Is Sigilon Therapeutics' short interest increasing or decreasing?

Sigilon Therapeutics saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 8,200 shares, a decline of 18.8% from the previous total of 10,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Sigilon Therapeutics' float size?

Sigilon Therapeutics currently has issued a total of 2,510,000 shares. Some of Sigilon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Sigilon Therapeutics currently has a public float of 1,420,000 shares.

How does Sigilon Therapeutics' short interest compare to its competitors?

0.58% of Sigilon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Sigilon Therapeutics: Apollomics, Inc. (0.09%), Hookipa Pharma Inc (0.75%), Rezolute, Inc. (2.14%), BriaCell Therapeutics Corp. (6.21%), Reneo Pharmaceuticals, Inc. (7.35%), Ocuphire Pharma, Inc. (7.64%), Clene Inc. (0.17%), Kezar Life Sciences, Inc. (4.20%), Gain Therapeutics, Inc. (0.68%), Enlivex Therapeutics Ltd. (0.86%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.34 billion), Occidental Petroleum Co. ($2.88 billion), Coinbase Global, Inc. ($2.50 billion), Rivian Automotive, Inc. ($2.47 billion), Palantir Technologies Inc. ($2.37 billion), Royal Caribbean Cruises Ltd. ($2.33 billion), T. Rowe Price Group, Inc. ($2.29 billion), Tractor Supply ($1.59 billion), Upstart Holdings, Inc. ($1.58 billion), and Enphase Energy, Inc. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Sigilon Therapeutics stock?

Short selling SGTX is an investing strategy that aims to generate trading profit from Sigilon Therapeutics as its price is falling. SGTX shares are trading down $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Sigilon Therapeutics?

A short squeeze for Sigilon Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SGTX, which in turn drives the price of the stock up even further.

How often is Sigilon Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SGTX, twice per month. The most recent reporting period available is July, 31 2023.



More Short Interest Resources from MarketBeat

This page (NASDAQ:SGTX) was last updated on 2/26/2024 by MarketBeat.com Staff